• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

suzuki susumu  鈴木 進

ORCIDConnect your ORCID iD *help
… Alternative Names

Suzuki Susumu  鈴木 進

SUZUKI Susumu  鈴木 進

Less
Researcher Number 70518422
Other IDs
Affiliation (Current) 2025: 愛知医科大学, 研究創出支援センター, 教授
Affiliation (based on the past Project Information) *help 2023 – 2024: 愛知医科大学, 研究創出支援センター, 教授
2022 – 2023: 愛知医科大学, 加齢医科学研究所, 准教授
2022: 愛知医科大学, 研究創出支援センター, 准教授
2019 – 2021: 愛知医科大学, 公私立大学の部局等, 准教授
2018: 愛知医科大学, その他部局等, 准教授
2014 – 2017: 愛知医科大学, 医学部, 准教授
2012: 愛知医科大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics
Except Principal Investigator
Basic Section 56030:Urology-related / Basic Section 56050:Otorhinolaryngology-related / Obstetrics and gynecology / Basic Section 54010:Hematology and medical oncology-related / Otorhinolaryngology / Tumor immunology
Keywords
Principal Investigator
CCR4 / 制御性T細胞 / モガムリズマブ / 細胞傷害性T細胞 / がん免疫治療 / CTL / Treg / 疲弊T細胞 / cytotoxic T-cell / immunotherapy … More / regulatory T-cell / RNAscope / TGF-b / CAF / M2マクロファージ / ADCC / MEK / TGF-β / ケモカイン受容体4 / 抗体依存性細胞傷害 / トラメチニブ / TGFb / 口腔癌 / NK細胞 / バイオマーカー / 多重免疫染色 / フローサイトメトリー / 免疫治療 / 免疫抑制 / がん微小環境 / 免疫療法 / PD-1 / FOXP3 / 頭頸部扁平上皮がん / 免疫抑制環境 / がん複合免疫治療 / 免疫チェックポイント / がん複合免疫療法 / キイトルーダ / オプジーボ / 免疫チェックポイント阻害剤 / CMVpp65 / FoxP3 / 腫瘍免疫増強 / 免疫不全マウス / CCケモカイン受容体4(CCR4) / エフェクター制御性T細胞 … More
Except Principal Investigator
免疫治療 / 頭頸部癌 / 腫瘍免疫学 / 頭頸部外科学 / 進行腎癌一次治療 / バイオマーカー / 制御性T細胞 / 腎癌 / 免疫 / 頸部郭清術 / 外科腫瘍免疫学 / ファージ抗体 / 組み換え型抗体 / 子宮頚がん / 細胞膜透過性ペプチド / HPV-E7 / 組換え型抗体 / 子宮頸がん / ペプチド / 子宮がん / scFv / antibody / HPV18-E7 / HPV16-E7 / cell-penetrating peptide / 膜貫通 / 抗体 / HPV / 遺伝子変異 / alemtuzumab / ヒト急性白血病 / アレンツムマブ / 化合物ライブラリー / アレンツズマブ / CRISPR-Csa9 / ITD / アレムツズマブ / ゲノム編集 / CRISPR-cas9 / 白血病 / CD52 / FLT3 / プロテオーム / 癌 / 細胞性免疫 / eTreg / 抗がん薬治療 / 免疫治療学 / 抗CCR4抗体 / Tax / HTLV-1 / NOGマウス / ATL / CTL / Treg / モガムリズマブ / 細胞傷害性T細胞(CTL) / CT 抗原 / 制御性T細胞(Treg) / CCR4 / 低フコシル化抗体 Less
  • Research Projects

    (10 results)
  • Research Products

    (85 results)
  • Co-Researchers

    (27 People)
  •  Development of novel Treg targeting cancer immunotherapy based on Treg immune suppressive mechanism in cancerPrincipal Investigator

    • Principal Investigator
      鈴木 進
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Aichi Medical University
  •  制御性T細胞の機能に着目した進行腎癌一次治療の選択に有用なバイオマーカーの 探索

    • Principal Investigator
      金尾 健人
    • Project Period (FY)
      2022 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Saitama Medical University
  •  Development of novel cancer immunotheray by combining regulatory T-cell elimination and TGF-b inhibitorsPrincipal Investigator

    • Principal Investigator
      Suzuki Susumu
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Aichi Medical University
  •  頸部リンパ節における腫瘍免疫環境の解明-免疫学的頸部郭清術の確立を目指して

    • Principal Investigator
      小川 徹也
    • Project Period (FY)
      2021 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56050:Otorhinolaryngology-related
    • Research Institution
      Aichi Medical University
  •  Development of the novel target therapy for leukemia with FLT3 mutations, using genetically modified FLT3-mutation knock-in human myeloid leukemia cells

    • Principal Investigator
      Hanamura Ichiro
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Aichi Medical University
  •  Basic research for development of novel cancer immunotherapy based on improvement of the cancer immunosuppressive microenvironmentPrincipal Investigator

    • Principal Investigator
      Suzuki Susumu
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Aichi Medical University
  •  Development of a New Immunochemotherapy for Head and Neck Cancer - Significance of Combination of CTL and Anticancer Drugs

    • Principal Investigator
      Ogawa Tetsuya
    • Project Period (FY)
      2017 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Otorhinolaryngology
    • Research Institution
      Aichi Medical University
  •  Development of Intracellular Molecularly Targeted Therapy Targeting E7 Protein of HPV that Initiates Cervical Cancer

    • Principal Investigator
      Yoshikawa Kazuhiro
    • Project Period (FY)
      2017 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Aichi Medical University
  •  Development of novel cancer immunotherapy based on comprehensive control of effector regulatory T-cellsPrincipal Investigator

    • Principal Investigator
      Suzuki Susumu
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Aichi Medical University
  •  Development of comprehensive immunotherapy by defuccosylated antibody

    • Principal Investigator
      UEDA Ryuzo
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Tumor immunology
    • Research Institution
      Aichi Medical University
      Nagoya City University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 Other

All Journal Article Presentation Book Patent

  • [Book] 最新医学2016

    • Author(s)
      鈴木進、中山睿一、黒瀬浩史、上田龍三 モガムリズマブの新しい展開
    • Total Pages
      7
    • Publisher
      最新医学社
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Book] 臨床血液2015

    • Author(s)
      正木彩子, 石田高司、 前田 康弘、 鈴木進、上田龍三、飯田真介
    • Total Pages
      10
    • Publisher
      臨床血液学会
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Book] Progress in clinical use of CCR4 antibody for regulatory T cell suppression. Inflammation and Immunity in Cancer.2015

    • Author(s)
      Suzuki S, Ishida T, Yoshikawa K, Ueda R.
    • Total Pages
      11
    • Publisher
      Springer
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Book] Clinical application of anti-CCR4 monoclonal antibody. Recent advances in cancer immunotherapy2014

    • Author(s)
      Ueda R, Suzuki S, Yoshikawa K, Ishida T.
    • Total Pages
      6
    • Publisher
      Princess Takamatsu Cancer Research Fund
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Book] Progress in clinical use of CCR4 antibody for Treg cell suppression.

    • Author(s)
      Suzuki S, Ishida T, Yoshikawa K and Ueda R.
    • Publisher
      Inflammation and Immunity in Cancer
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Journal Article] Regulatory T-cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer2024

    • Author(s)
      Suzuki S, Tsuzuki T, Saito M, Ishii T, Takahara T, Satou A, Inukai D, Yamanaka S, Yoshikawa K, Ueda R, Ogawa T
    • Journal Title

      Pathology International

      Volume: -

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K07203
  • [Journal Article] Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens2023

    • Author(s)
      Yamanaka S, Suzuki S, Ito H, Sivasundaram K, Hanamura I, Okubo I, Yoshikawa K, Ono S, Takahara T, Satou A, Tsuzuki T, Ueda R, Ogawa T, Fujimoto Y.
    • Journal Title

      International journal of molecular sciences

      Volume: 24 Issue: 2 Pages: 1722-1722

    • DOI

      10.3390/ijms24021722

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K07203, KAKENHI-PROJECT-21K08427, KAKENHI-PROJECT-20K16205, KAKENHI-PROJECT-17K11301, KAKENHI-PROJECT-19K09292, KAKENHI-PROJECT-22K08516, KAKENHI-PROJECT-22K08985
  • [Journal Article] Immune Status of Cervical Lymph Nodes in Head and Neck Cancer-A Surgical Oncology Perspective2023

    • Author(s)
      Hiromu Nakamura, Tetsuya Ogawa, Shunpei Yamanaka, Daisuke Inukai, Takashi Maruo, Taishi Takahara, Akira Satou, Toyonori Tsuzuki, Susumu Suzuki, Ryuzo Ueda, Yasushi Fujimoto
    • Journal Title

      Immune Status of Cervical Lymph Nodes in Head and Neck Cancer-A Surgical Oncology Perspective

      Volume: 13 Issue: 7 Pages: 11741183-11741183

    • DOI

      10.3390/jpm13071174

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09664, KAKENHI-PROJECT-21K07203
  • [Journal Article] In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients2022

    • Author(s)
      Kondo Y, Suzuki S, Ono S, Goto M, Miyabe S, Ogawa T, Tsuchida H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Ueda R, Nagao T.
    • Journal Title

      International journal of molecular sciences

      Volume: 23 Issue: 8 Pages: 4077-4077

    • DOI

      10.3390/ijms23084077

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07203
  • [Journal Article] An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line.2022

    • Author(s)
      Sakuma K, Kii T, Takahashi H, Suzuki S, Yoshikawa K, Ogawa T, Tanaka A.
    • Journal Title

      Ainticancer Research

      Volume: 42 Issue: 9 Pages: 4293-4303

    • DOI

      10.21873/anticanres.15929

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K07203, KAKENHI-PROJECT-17K11301, KAKENHI-PROJECT-19K19214
  • [Journal Article] Trametinib improves Treg selectivity of anti-CCR4 antibody by regulating CCR4 expression in CTLs in oral squamous cell carcinoma2022

    • Author(s)
      Ono S, Suzuki S, Kondo Y, Okubo I, Goto M, Ogawa T, Kato H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Nagao T, Ueda R.
    • Journal Title

      Scientific Reports

      Volume: 12 Issue: 1 Pages: 21678-21678

    • DOI

      10.1038/s41598-022-22773-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07203, KAKENHI-PROJECT-17K11301
  • [Journal Article] Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma2021

    • Author(s)
      Kondo Yutaro、Suzuki Susumu、Takahara Taishi、Ono Shoya、Goto Mitsuo、Miyabe Satoru、Sugita Yoshihiko、Ogawa Tetsuya、Ito Hideaki、Satou Akira、Tsuzuki Toyonori、Yoshikawa Kazuhiro、Ueda Ryuzo、Nagao Toru
    • Journal Title

      Cancer Science

      Volume: 112 Issue: 10 Pages: 4037-4049

    • DOI

      10.1111/cas.15081

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K10081, KAKENHI-PROJECT-21K07203
  • [Journal Article] Combining T‐cell‐based immunotherapy with venetoclax elicits synergistic cytotoxicity to B‐cell lines in vitro2020

    • Author(s)
      Murakami Satsuki、Suzuki Susumu、Hanamura Ichiro、Yoshikawa Kazuhiro、Ueda Ryuzo、Seto Masao、Takami Akiyoshi
    • Journal Title

      Hematological Oncology

      Volume: 38 Issue: 5 Pages: 705-714

    • DOI

      10.1002/hon.2794

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K08343, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-17K11301
  • [Journal Article] Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy2020

    • Author(s)
      Inukai Daisuke、Kan Taichi、Yamanaka Shunpei、Okamoto Hiroki、Fujimoto Yasushi、Ito Takanori、Taniguchi Natsuki、Yamamoto Yuuki、Tsuzuki Toyonori、Takami Akiyoshi、Ogawa Tetsuya
    • Journal Title

      Microorganisms

      Volume: 8 Issue: 10 Pages: 1497-1497

    • DOI

      10.3390/microorganisms8101497

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K11412, KAKENHI-PROJECT-18K08343
  • [Journal Article] Immune-checkpoint molecules on regulatory T-cells as potential therapeutic target in head and neck squamous cell cancers.2020

    • Author(s)
      Suzuki S, Ogawa T, Sano R, Takahara T, Inukai D, Satou A, Tsuchida H, Yoshikawa K, Ueda R, Tsuzuki T
    • Journal Title

      Cancer Sci.

      Volume: in press Issue: 6 Pages: 1943-1957

    • DOI

      10.1111/cas.14422

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-17K11412, KAKENHI-PROJECT-20K18327, KAKENHI-PROJECT-17K11301
  • [Journal Article] Clinical significance of tryptophan catabolism in follicular lymphoma2020

    • Author(s)
      Masaki Ayako、Ishida Takashi、Maeda Yasuhiro、Ito Asahi、Suzuki Susumu、Narita Tomoko、Kinoshita Shiori、Yoshida Takashi、Ri Masaki、Kusumoto Shigeru、Komatsu Hirokazu、Inagaki Hiroshi、Ueda Ryuzo、Choi Ilseung、Suehiro Youko、Iida Shinsuke
    • Journal Title

      Hematological Oncology

      Volume: 38 Issue: 5 Pages: 742-753

    • DOI

      10.1002/hon.2804

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-18H02633, KAKENHI-PROJECT-18K07277
  • [Journal Article] Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma2020

    • Author(s)
      Saito Masato、Ishii Toshihiko、Urakawa Itaru、Matsumoto Asuka、Masaki Ayako、Ito Asahi、Kusumoto Shigeru、Suzuki Susumu、Takahashi Takeshi、Morita Akimichi、Inagaki Hiroshi、Iida Shinsuke、Ishida Takashi
    • Journal Title

      Blood Advances

      Volume: 4 Issue: 10 Pages: 2180-2191

    • DOI

      10.1182/bloodadvances.2020001641

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-18K07277
  • [Journal Article] Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.2019

    • Author(s)
      Watanabe M, Kanao K, Suzuki S, Muramatsu H, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Kato Y, Zennami K, Nakamura K, Tsuzuki T, Yoshikawa K, Ueda R, Sumitomo M.
    • Journal Title

      Prostate

      Volume: 79(14) Issue: 14 Pages: 1658-1665

    • DOI

      10.1002/pros.23890

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11163, KAKENHI-PROJECT-18K07210, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K16715, KAKENHI-PROJECT-17K11301
  • [Journal Article] Mogamulizumab treatment elicits autoantibodies attacking the skin in patients with adult T cell leukemia-lymphoma2019

    • Author(s)
      Suzuki Yui、Saito Masato、Ishii Toshihiko、Urakawa Itaru、Matsumoto Asuka、Masaki Ayako、Ito Asahi、Kusumoto Shigeru、Suzuki Susumu、Hiura Masanori、Takahashi Takeshi、Morita Akimichi、Inagaki Hiroshi、Iida Shinsuke、Ishida Takashi
    • Journal Title

      Clinical Cancer Research

      Volume: 印刷中 Issue: 14 Pages: 4388-4399

    • DOI

      10.1158/1078-0432.ccr-18-2575

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-16H04713, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18H02633
  • [Journal Article] Targeting lactate dehydrogenase-A promotes docetaxe-induced cytotoxicity predominantly in castration-resistant prostate cancer cells.2019

    • Author(s)
      Muramatsu H, Sumitomo M, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Kato Y, Watanabe M, Zennami K, Kanao K, Nakamura K, Suzuki S, Yoshikawa K.
    • Journal Title

      Oncol Rep.

      Volume: 42(1) Pages: 224-230

    • DOI

      10.3892/or.2019.7171

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11163, KAKENHI-PROJECT-17K11301
  • [Journal Article] CCR4 expression in tumor-infiltrating regulatory T cells in patients with squamous cell carcinoma of the lung: A prognostic factor for relapse and survival2019

    • Author(s)
      Kubo A, Asai N, Suzuki S, Murotani K, Numanami H, Yoshikawa K, Ueda R, Yamaguchi E
    • Journal Title

      Cancer Invest

      Volume: 37 Issue: 3 Pages: 163-73

    • DOI

      10.1080/07357907.2019.1582848

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K07128, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-17K11301
  • [Journal Article] Immunomodulatory and Metabolic Changes after Gnetin-C Supplementation in Humans.2019

    • Author(s)
      Nakagami Y, Suzuki S, Espinoza JL, Vu Quang L, Enomoto M, Takasugi S, Nakamura A, Nakayama T, Tani H, Hanamura I, Takami A
    • Journal Title

      Nutrients

      Volume: 11 Issue: 6 Pages: 1403-1403

    • DOI

      10.3390/nu11061403

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K08343, KAKENHI-PROJECT-17K09944
  • [Journal Article] Increased Tim-3+ T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patients.2018

    • Author(s)
      Kato R, Yamasaki M, Urakawa S, Nishida K, Makino T, Morimoto-Okazawa A, Kawashima A, Iwahori K, Suzuki S, Ueda R, Mori M, Satoh T, Doki Y, Wada H.
    • Journal Title

      Cancer Immunol Immunother.

      Volume: 67 Issue: 11 Pages: 1673-1683

    • DOI

      10.1007/s00262-018-2225-x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Journal Article] Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.2018

    • Author(s)
      Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Iida S.
    • Journal Title

      Cancer Sci

      Volume: 109 Issue: 8 Pages: 2383-2390

    • DOI

      10.1111/cas.13654

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K16095, KAKENHI-PROJECT-16H04713, KAKENHI-PROJECT-18H02633
  • [Journal Article] Generation of PTEN?knockout (-/-) murine prostate cancer cells using the CRISPR/Cas9 system and comprehensive gene expression profiling2018

    • Author(s)
      Takao Akiko、Yoshikawa Kazuhiro、Karnan Sivasundaram、Ota Akinobu、Uemura Hirotsugu、De Velasco Marco、Kura Yurie、Suzuki Susumu、Ueda Ryuzo、Nishino Tokiko、Hosokawa Yoshitaka
    • Journal Title

      Oncology Reports

      Volume: 40 Pages: 2455-2466

    • DOI

      10.3892/or.2018.6683

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K11165, KAKENHI-PROJECT-18K08342, KAKENHI-PROJECT-17K11301
  • [Journal Article] Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study2017

    • Author(s)
      Nishio-Nagai Mayako、Suzuki Susumu、Yoshikawa Kazuhiro、Ueda Ryuzo、Kazaoka Yoshiaki
    • Journal Title

      International Journal of Oncology

      Volume: 51 Issue: 5 Pages: 1471-1481

    • DOI

      10.3892/ijo.2017.4142

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Journal Article] モガムリズマブの新しい展開2016

    • Author(s)
      鈴木進、中山睿一、黒瀬浩史、上田龍三
    • Journal Title

      最新医学

      Volume: 71 Pages: 126-132

    • NAID

      40020708354

    • Data Source
      KAKENHI-PROJECT-26430173
  • [Journal Article] がん細胞に対する抗体の現状と展望2016

    • Author(s)
      鈴木進、吉川和宏、上田龍三
    • Journal Title

      実験医学

      Volume: 34 Pages: 122-131

    • Data Source
      KAKENHI-PROJECT-26430173
  • [Journal Article] Current status of immunotherapy.2016

    • Author(s)
      Suzuki S, Ishida T, Yoshikawa K and Ueda R.
    • Journal Title

      Jpn J Clin Oncol

      Volume: 46 Issue: 3 Pages: 191-203

    • DOI

      10.1093/jjco/hyv201

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-24592415
  • [Journal Article] Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.2015

    • Author(s)
      2.Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R, Nakayama E.
    • Journal Title

      Clin Cancer Res.

      Volume: 21 Issue: 19 Pages: 4327-36

    • DOI

      10.1158/1078-0432.ccr-15-0357

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-15K14403, KAKENHI-PROJECT-25430161, KAKENHI-PROJECT-26670237, KAKENHI-PROJECT-26670581, KAKENHI-PROJECT-26830117, KAKENHI-PROJECT-25290058, KAKENHI-PROJECT-26290054, KAKENHI-PROJECT-26290056
  • [Journal Article] Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.2015

    • Author(s)
      Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Ogura H, Totani H, Yoshida T, Kinoshita S, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S.
    • Journal Title

      Clin Cancer Res.

      Volume: -

    • NAID

      130005130183

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Journal Article] Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma2015

    • Author(s)
      Masaki, A., Ishida, T., Maeda, Y., Suzuki, S., Ito, A., Takino, H., Ogura, H., Totani, H., Yoshida, T., Kinoshita, S., Narita, T., Ri, M., Kusumoto, S., Inagaki, A., Komatsu, H., Niimi, A., Ueda, R., Utsunomiya, A., Inagaki, H. & Iida, S.
    • Journal Title

      Clinical cancer research : an official journal of the American Association for Cancer Research

      Volume: 21 (12) Issue: 12 Pages: 2830-2839

    • DOI

      10.1158/1078-0432.ccr-14-2275

    • NAID

      130005130183

    • Description
      印刷中
    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-221S0001, KAKENHI-PROJECT-15K08351, KAKENHI-PROJECT-26430173, KAKENHI-PROJECT-25290058
  • [Journal Article] モガムリズマブ2014

    • Author(s)
      鈴木 進, 石田 高司, 吉川 和宏, 上田 龍三
    • Journal Title

      The Frontiers in Life Sciences. 生命科学から創薬へのイノベーション

      Volume: 1 Pages: 183-195

    • Data Source
      KAKENHI-PROJECT-26430173
  • [Journal Article] Autologous Tax-Specific CTL Therapy in a Primary Adult T Cell Leukemia/Lymphoma Cell-Bearing NOD/Shi-scid2013

    • Author(s)
      Ishida T, Suzuki S, Ueda R.
    • Journal Title

      IL-2Rγnull Mouse Model. J Immunol

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Journal Article] Angioimmunoblastic T-cell lymphoma mice model2013

    • Author(s)
      Ishida T, Suzuki S, Ueda R
    • Journal Title

      Leuk Res

      Volume: 37 Pages: 21-7

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Journal Article] Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma2012

    • Author(s)
      Suzuki S, Ishida T, Ueda R.
    • Journal Title

      Cancer Sci

      Volume: 103 Pages: 1764-73

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Journal Article] Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.2012

    • Author(s)
      Suzuki S
    • Journal Title

      Cancer Sci.

      Volume: 103 Issue: 10 Pages: 1764-73

    • DOI

      10.1111/j.1349-7006.2012.02371.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-22300333, KAKENHI-PROJECT-22689029, KAKENHI-PROJECT-23300354, KAKENHI-PROJECT-24590422, KAKENHI-PROJECT-221S0001
  • [Patent] エフェクター制御性T細胞の検出と調整2018

    • Inventor(s)
      鈴木進、吉川和宏
    • Industrial Property Rights Holder
      愛知医科大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2018
    • Acquisition Date
      2022
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Presentation] T-cell receptor repertoire similarity in regulatory T-cells between draining lymph nodes and cancer tissues.2023

    • Author(s)
      Suzuki S, Saito M, Ishii T, Takahara T, Satou A, Inukai D, Yamanaka S, Yoshikawa K, Tsuzuki T, Ueda R and Ogawa T.
    • Organizer
      2nd JCA-AACR Precision Cancer Medicine International Conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21K07203
  • [Presentation] Establishment passive culture cells derived from mucoepidermoid carcinoma2022

    • Author(s)
      Shunpei Yamanaka, Susumu Suzuki, Hideaki Ito, Shoya Ono, Yutaro Kondo, Daisuke Inukai, Hiroki Okamoto, Taishi Takahara, Toyonori Tsuzuki, Kazuhiro Yoshikawa, Ryuzo Ueda, Tetsuya Ogawa
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Presentation] Transforming growth factor-beta inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma2022

    • Author(s)
      Yutaro Kondo, Taishi Takahara, Shoya Ono, Mitsuo Goto, Tetsuya Ogawa, Hideaki Ito, Akira Sato, Toyonori Tsuzuki, Kazuhiro Yoshikawa, Ryuzo Ueda, Susumu Suzuki
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Presentation] Trametinib improves Treg selectivity of anti-CCR4 mAb by regulating CCR4 expression in CTLs induced via TCR/TGF-β signaling2022

    • Author(s)
      Ono S, Suzuki S, Kondo Y, Okubo I, Goto M, Ogawa T, Kato H, Ito H, Takahara T, Satou A, Tsuzuki T, Yoshikawa K, Nagao T, Ueda R.
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-21K07203
  • [Presentation] Transforming growth factor-β inhibitor is a candidate drug for immunotherapy of oral squamous cell carcinoma2021

    • Author(s)
      Kondo Y, Suzuki S, Takahara T, Ono S, Goto M, Miyabe S, Sugita Y, Ogawa T, Ito H, Satou A, Tsuzuki T, Yoshikawa K, Ueda R, Nagao T.
    • Organizer
      第80回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-21K07203
  • [Presentation] CD52 is a novel target for the treatment of FLT3-ITD mutated leukemia2021

    • Author(s)
      花村 一朗, カルナン シバンスンダラン, 太田 明伸, 鈴木 進, 高杉 壮一, 中村 文乃, 高橋 美裕希, 村上 五月, 上田 龍三, 細川 好孝, 高見 昭良
    • Organizer
      第83回日本血液学会学術集会
    • Data Source
      KAKENHI-PROJECT-19K08825
  • [Presentation] Comparison of eTreg frequency status between metastatic and non-metastatic lymphnodes in head and neck cancer2020

    • Author(s)
      Ogawa T, Suzuki S, Sano R, Inukai D, Okamoto H, Takahara T, Yoshikawa K, Ueda R, Tsuzuki T
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Synergistic Effect of Venetoclax for Antibody Dependent Cell Cytotoxicity By Daratumumab2020

    • Author(s)
      Ayano Nakamura, Susumu Suzuki, Masao Seto, Souichi Takasugi, Jo Kanasugi, Ichiro Hanamura, Ryuzo Ueda, Akiyoshi Takami
    • Organizer
      62nd ASH annual meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] PD-L1 expression mechanisms are heterogeneous in oral cancer2020

    • Author(s)
      Kondo Y, Suzuki S, Goto M, Ono Syoya, Ogawa T, Yoshikawa K, Tuzuki T, Ueda R
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Analysis of frequency and TCR repertoires of regulatory T-cell (Treg) of drain lymph node in head and neck cancer2020

    • Author(s)
      Suzuki S, Ogawa T, Sano R, Inukai D, Okamoto H, Takahara T, Sito M, Ishii T, Yoshikawa K, Ueda R, Tsuzuki T
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Characterization of tumor immune-microenvironmen (TIME) in papillary thyroid cancer (PTC).2019

    • Author(s)
      Okamoto H, Suzuki S, Ogawa T, Inukai D, Sano R, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
    • Organizer
      第78回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Development New Strategy for Head and Neck Immunotherapy from the Perspective of Translational and Reverse Translational Research2019

    • Author(s)
      Ogawa T, Okamoto H, Inukai D, Sano R, Yamanaka S, Ueda H, Takahara T, Tsuzuki T, Yoshikawa K, Suzuki S, Ueda R
    • Organizer
      第57回日本癌治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] New strategy of immunotherapy for head and neck squamous cell cancers (HNSCCs) combined with IC and Treg inhibitors.2019

    • Author(s)
      Suzuki S, Ogawa T, Inukai D, Okamoto H, Sano R, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
    • Organizer
      第78回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Multicolor analysis of characterization of immuno-suppressive microenvironment in head & neck cancer.2019

    • Author(s)
      Sano R, Suzuki S, Ogawa T, Inukai D , Okamoto H, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
    • Organizer
      6th Asian society of head and neck oncology.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11412
  • [Presentation] Characterization of immune-suppressive microenvironment in head & neck cancer2018

    • Author(s)
      佐野 塁,鈴木 進, 小川 徹也, 犬飼 大輔, 岡本 啓希, 高原 大志, 佐藤 啓, 吉川 和宏, 都築 豊徳, 上田 龍三
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Presentation] 頭頸部がん外科免疫治療の開発 手術検体を用いた腫瘍局所における免疫関連細胞・分子の解析から考える2018

    • Author(s)
      小川 徹也, 犬飼 大輔, 岡本 啓希, 山中 俊平, 佐野 塁, 植田 広海, 都築 豊徳, 鈴木 進, 吉川 和宏, 上田 龍三
    • Organizer
      日本頭頸部癌学会
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Presentation] Characterization of immune-suppressive microenvironment in head & neck cancer.2018

    • Author(s)
      1.Sano R, Suzuki S, Ogawa T, Inukai D, Okamoto H, Takahara T, Sato A, Yoshikawa K, Tsuzuki T, Ueda R.
    • Organizer
      第77回 日本癌学会総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Interim immunostaining results from phase I study of pre-operative combination therapy with mogamulizumab and nivolumab.2018

    • Author(s)
      2.Suzuki S, Tsuzuki T, Ishida T, Kojima T, Kakimi K, Iida S, Oka M, Doki Y, Nishikawa H, Ueda R, and Wada H.
    • Organizer
      第77回 日本癌学会総会
    • Data Source
      KAKENHI-PROJECT-18K07277
  • [Presentation] Characterization of immune-suppressive microenvironment in head & neck cancer.2018

    • Author(s)
      Sano R, Suzuki S, Ogawa T, Inukai D , Okamoto H, Takahara T, Satou A, Yoshikawa K, Tsuzuki T, Ueda R
    • Organizer
      第77回日本癌学会学術総会.
    • Data Source
      KAKENHI-PROJECT-17K11412
  • [Presentation] 頭頸部がん手術検体を用いたeffector Tregの腫瘍内発現の解析2017

    • Author(s)
      鈴木 進, 西村 邦宏, 小川 徹也, 都築 豊徳, 吉川 和宏, 上田 龍三
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-17K11301
  • [Presentation] CDK9 as target for treatment in EBV associated T- and NK-cell lymphoproliferative diseases.2016

    • Author(s)
      Kinoshita S, Ishida T, Narita T, Itou A, Masaki A, Suzuki S, Ri M, Kusumoto S, Komatsu H, Kuroda T, Inagaki H, Abe Y, Ueda R and Iida S.
    • Organizer
      第75回 日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Prognostic significance of tryptophan catabolism in newly diagnosed Hodgkin Lymphoma.2016

    • Author(s)
      Masaki A, Ishida T, Narita T, Itou A, Suzuki S, Kusumoto S, Komatsu H, Ilseung C, Suehiro Y, Abe Y, Inagaki H, Ueda R and Iida S.
    • Organizer
      第78回日本血液学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-13
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Prognostic significance of tryptophan catabolism in newly diagnosed Hodgkin Lymphoma.2016

    • Author(s)
      Masaki A, Ishida T, Narita T, Itou A, Suzuki S, Kusumoto S, Komatsu H, Ilseung C, Suehiro Y, Abe Y, Inagaki H, Ueda R and Iida S.
    • Organizer
      第75回 日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2016

    • Author(s)
      Ishida T, Ito A,Masaki A, Saito M, Urakawa I, Ishii T, Suzuki S, Kusumoto S, Komatsu H, Inagaki H, Iida S, Takahashi T and Ueda R.
    • Organizer
      第75回 日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2016

    • Author(s)
      Ishida T, Ito A,Masaki A, Saito M, Urakawa I, Ishii T, Suzuki S, Kusumoto S, Komatsu H, Inagaki H, Iida S, Takahashi T and Ueda R.
    • Organizer
      第78回日本血液学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-13
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] C-C chemokine receptor 4 positive regulatory T cells increased in biopsy specimens of poorly prognostic prostate cancer.2016

    • Author(s)
      Watanabe M, Kanao K, Suzuki S, Nakamura K, Yoshikawa K, Ueda R, and Sumitomo M. C-C chemokine receptor 4 positive regulatory T cells increased in biopsy specimens of poorly prognostic prostate cancer.
    • Organizer
      第75回 日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] 5-FU (fluorouracil) sensitizes oral squamous cell carcinoma (OSCC) to cytotoxic T-lymphocyte (CTL).2016

    • Author(s)
      Suzuki S, Nishio M, Ohmura Y, Yoshikawa K, Kazaoka Y and Ueda R.
    • Organizer
      第75回 日本癌学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] CDK9 as target for treatment in EBV associated T- and NK-cell lymphoproliferative diseases.2016

    • Author(s)
      Kinoshita S, Ishida T, Narita T, Itou A, Masaki A, Suzuki S, Ri M, Kusumoto S, Komatsu H, Kuroda T, Inagaki H, Abe Y, Ueda R and Iida S.
    • Organizer
      第78回日本血液学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-13
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients2015

    • Author(s)
      Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Suzuki S, Kakimi K, Nishikawa H, Ueda R, Oka M, Nakayama E.
    • Organizer
      第74回 日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients.2015

    • Author(s)
      Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R and Nakayama E.
    • Organizer
      第19回日本がん免疫学会総会
    • Place of Presentation
      東京
    • Year and Date
      2015-07-09
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Potential treatment of adult T-cell leukemia/lymphoma by a novel P-TEFb/CDK9 inhibitor BAY11435722015

    • Author(s)
      Narita T, Ishida T, Ito A, Masaki A, Suzuki S, Takino H, Ogura H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Imada K, Takaori KA, Inagaki H, Arne S, Stuart I, Ueda R, and Iida S.
    • Organizer
      第77回 日本血液学会学術集会
    • Place of Presentation
      金沢
    • Year and Date
      2015-10-16
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2015

    • Author(s)
      Masaki A, Ishida T, Meda Y, Suzuki S, Ito A, Ogura H, Narita T, Totani H, Kinoshita S, Yoshida T, Ri M, Kusumoto S, Komatsu H, Ueda R, Inagaki H and Iida S.
    • Organizer
      第77回 日本血液学会学術集会
    • Place of Presentation
      金沢
    • Year and Date
      2015-10-16
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Indoleamine 2,3-dioxygenase 1 as a novel molecular target in adult T-cell leukemia/lymphoma.2015

    • Author(s)
      Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Ri M, Kusumoto S, Komatsu H, Ueda R, Inagaki H, Iida S.
    • Organizer
      第74回 日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Immunotherapy for solid tumors based on regulation of regulatory T lymphocyte.2015

    • Author(s)
      Suzuki S, Ishida T, Kurose K, Ohue Y, Nishikawa H, Iida S, Wada H, Oka M, Nakayama E and Ueda R.
    • Organizer
      第74回 日本癌学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] 成人T細胞性白血病/リンパ腫におけるindoleamine 2,3-dioxygenaseの臨床的意義.2014

    • Author(s)
      正木彩子、石田高司、前田康博、稲垣淳、鈴木進、伊藤旭、成田朋子、榊原健夫、滝野寿、李政樹、楠本茂、小松弘和、上田龍三、稲垣宏、宇都宮與、飯田真介
    • Organizer
      第54回日本リンパ網内系学会総会
    • Place of Presentation
      山形
    • Year and Date
      2014-06-21
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Chemo-immunotherapy with CTL and 5-fluorouracil (5FU) for head and neck squamous cell carcinoma (HNSCC).2014

    • Author(s)
      Nishio-Nagai M, Suzuki S, Hayashi T, Ohmura Y, Yamada Y, Yoshikawa K, Ueda R and Kazaoka Y.
    • Organizer
      22nd Annual International Cancer Immunotherapy Symposium.
    • Place of Presentation
      ニューヨーク
    • Year and Date
      2014-10-05
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] 口頸部扁平上皮癌(HNSCC)における5-フルオロウラシル(5-FU)併用免疫療法.2014

    • Author(s)
      西尾麻矢子、鈴木 進、大村元伸、山田陽一、上田龍三、吉川和宏、風岡宜暁
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-27
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] CCR4を標的抗原とする、新規がん免疫療法.2014

    • Author(s)
      石田高司、鈴木 進、上田龍三
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-26
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] 制御性T細胞解析方法の標準化に向けた多施設共同研究2014

    • Author(s)
      長瀬博次、和田 尚、西川博嘉、鈴木 進、平家勇司、小嶋隆嗣、垣見和宏、舩越 建、飯田真介、石田高司、佐藤永一、鵜殿平一郎、岡三喜男、中山睿一、土岐祐一郎、上田龍三
    • Organizer
      第18回日本がん免疫学会総会
    • Place of Presentation
      松山
    • Year and Date
      2014-07-31
    • Data Source
      KAKENHI-PROJECT-26430173
  • [Presentation] Development of CTL preparation kit for adoptive T cell immunotherapy.2013

    • Author(s)
      Suzuki S, Ueda R.(他3名)
    • Organizer
      20th Annual Cancer Research Institute International Symposium. Cancer Immunotherapy 2012
    • Place of Presentation
      New York
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Development of CTL preparation kit for adoptive T cell immunotherapy.2012

    • Author(s)
      Suzuki S
    • Organizer
      20th Annual Cancer Research Institute International Symposium. Cancer Immunotherapy
    • Place of Presentation
      New York
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Potent Tax-specific CTL response to primary autologous ATL cells2011

    • Author(s)
      鈴木進
    • Organizer
      第73回日本血液学会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2011-10-16
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Bevacizumab-induced potent antitumor effect in a microenvironment-dependentmouse lymphoma model.2011

    • Author(s)
      石田高司、鈴木進、上田龍三(他8名)
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Enhancement of HTLV-1 tax protein expression and the response of tax specific CTL by HDAC inhibitor.2011

    • Author(s)
      SuzukiS,IshidaT,UedaR.(他11名)
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Enhancement of HTLV-1 tax protein expression and the response of tax specific CTL by HDAC inhibitor.

    • Author(s)
      Suzuki S, Ishida T, Ueda R. (他 9 名)
    • Organizer
      The 73th Annual Meeting of the Japanese Society of Hematology
    • Place of Presentation
      Nagoya
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Potent antitumor effects of bevacizumab in a microenviroment-dependent human ATL

    • Author(s)
      Ishida T, Suzuki S, Ueda R,(他14名)
    • Organizer
      The 74th Annual Meeting of the Japanese Society of Hematology
    • Place of Presentation
      京都
    • Data Source
      KAKENHI-PROJECT-22300333
  • [Presentation] Autologous Tax-specific CTL therapy in a primary ATL cell-bearing NOG mouse model.

    • Author(s)
      Ishida T, Suzuki S, Ueda R.(他9名)
    • Organizer
      The 74th Annual Meeting of the Japanese Society of Hematology
    • Place of Presentation
      京都
    • Data Source
      KAKENHI-PROJECT-22300333
  • 1.  Ogawa Tetsuya (40334940)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 20 results
  • 2.  Yoshikawa Kazuhiro (60109759)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 17 results
  • 3.  都築 豊徳 (70627645)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 1 results
  • 4.  UEDA Ryuzo (20142169)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 39 results
  • 5.  Hanamura Ichiro (70440740)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 3 results
  • 6.  シバスンダラン カルナン (30557096)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 7.  ISHIDA Takashi (80405183)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 10 results
  • 8.  伊藤 旭 (00571762)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 12 results
  • 9.  佐野 塁 (50813846)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 7 results
  • 10.  太田 明伸 (30438048)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 11.  藪下 廣光 (00140046)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 12.  土本 純 (70632868)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 13.  金尾 健人 (20327620)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 14.  MIYABE Satoru
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 15.  NAGAO Toru
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 16.  SUMITOMO Makoto
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 2 results
  • 17.  UEMURA Hirotsugu
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 18.  DEVELASCO Marco
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 19.  ITO Hidemi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 20.  SUZUKI Hiromu
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 21.  KUBO Akihito
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 22.  高見 昭良
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 23.  正木 彩子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 3 results
  • 24.  鈴木 登
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 25.  鈴木 貞夫
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 26.  鈴木 操
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 27.  吉田 稔
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi